Celularity, a leading U.S. biotechnology company, is seizing on an opportunity to use cells to target diseases. The CEO, Dr. Robert Hariri, says placenta can be used to augment longevity and immunity. https://www.celularity.com

Celularity’s Massively Transformative Purpose (MTP) is to harness the power of the living cell to augment biology, immunity and longevity.

/redirect?q=http%3A%2F%2Fwww.foxbusiness.com%2Ffeatures%2F2018%2F02%2F15%2Fbiotech-breakthrough-placenta-makes-100-years-old-new-60-research-finds.html&v=jkQV3gUua_8&event=video_description&redir_token=QKlLB38bGZR8iE-br1upaZX8KUh8MTUyMDg4MzgwNEAxNTIwNzk3NDA0